-
1دورية أكاديمية
المؤلفون: Kooshkaki O., Derakhshani A., Hosseinkhani N., Torabi M., Safaei S., Brunetti O., Racanelli V., Silvestris N., Baradaran B.
المساهمون: Kooshkaki, O., Derakhshani, A., Hosseinkhani, N., Torabi, M., Safaei, S., Brunetti, O., Racanelli, V., Silvestris, N., Baradaran, B.
مصطلحات موضوعية: Cancer, combination therapy, immune checkpoint inhibitors, ipilimumab, nivolumab
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32580338; info:eu-repo/semantics/altIdentifier/wos/WOS:000553479400001; volume:21; issue:12; Article number 4427; firstpage:1; lastpage:28; numberofpages:28; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/11570/3233976Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087098725; https://www.mdpi.com/1422-0067/21/12/4427Test
الإتاحة: https://doi.org/10.3390/ijms21124427Test
http://hdl.handle.net/11570/3233976Test
https://www.mdpi.com/1422-0067/21/12/4427Test -
2دورية أكاديمية
المؤلفون: Kooshkaki O., Derakhshani A., Hosseinkhani N., Torabi M., Safaei S., Brunetti O., Racanelli V., Silvestris N., Baradaran B.
المساهمون: Kooshkaki, O., Derakhshani, A., Hosseinkhani, N., Torabi, M., Safaei, S., Brunetti, O., Racanelli, V., Silvestris, N., Baradaran, B.
مصطلحات موضوعية: cancer, combination therapy, immune checkpoint inhibitor, ipilimumab, nivolumab
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32580338; info:eu-repo/semantics/altIdentifier/wos/WOS:000553479400001; volume:21; issue:12; firstpage:4427; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/11586/309928Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087098725
-
3دورية أكاديمية
المؤلفون: Kooshkaki O., Derakhshani A., Hosseinkhani N., Torabi M., Safaei S., Brunetti O., Racanelli V., Silvestris N., Baradaran B.
المساهمون: Kooshkaki, O., Derakhshani, A., Hosseinkhani, N., Torabi, M., Safaei, S., Brunetti, O., Racanelli, V., Silvestris, N., Baradaran, B.
مصطلحات موضوعية: cancer, combination therapy, immune checkpoint inhibitor, ipilimumab, nivolumab
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32580338; info:eu-repo/semantics/altIdentifier/wos/WOS:000553479400001; volume:21; issue:12; firstpage:4427; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11572/386893Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087098725
